Moderna, Inc. (MRNA)
NASDAQ: MRNA · Real-Time Price · USD
53.72
-0.96 (-1.76%)
At close: Apr 17, 2026, 4:00 PM EDT
53.70
-0.02 (-0.04%)
After-hours: Apr 17, 2026, 5:44 PM EDT
Moderna Stock Forecast
Stock Price Forecast
The 11 analysts that cover Moderna stock have a consensus rating of "Hold" and an average price target of $34.27, which forecasts a -36.21% decrease in the stock price over the next year. The lowest target is $18 and the highest is $69.
Price Target: $34.27 (-36.21%)
Analyst Consensus: Hold
Analyst Ratings
The average analyst rating for Moderna stock is "Hold". This means that analysts believe this stock is likely to perform similarly to the overall market.
Recommendation Trends
| Rating | Nov '25 | Dec '25 | Jan '26 | Feb '26 | Mar '26 | Apr '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 1 | 1 | 0 | 0 | 0 | 0 |
| Buy | 1 | 1 | 1 | 1 | 1 | 1 |
| Hold | 8 | 9 | 9 | 9 | 9 | 9 |
| Sell | 3 | 3 | 3 | 2 | 2 | 2 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 13 | 14 | 13 | 12 | 12 | 12 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Barclays | Barclays | Hold Maintains $25 → $48 | Hold | Maintains | $25 → $48 | -10.65% | Apr 2, 2026 |
| Piper Sandler | Piper Sandler | Buy Maintains $63 → $69 | Buy | Maintains | $63 → $69 | +28.44% | Feb 23, 2026 |
| Goldman Sachs | Goldman Sachs | Hold Maintains $36 → $41 | Hold | Maintains | $36 → $41 | -23.68% | Feb 17, 2026 |
| RBC Capital | RBC Capital | Hold Maintains $25 → $30 | Hold | Maintains | $25 → $30 | -44.15% | Feb 17, 2026 |
| Evercore ISI Group | Evercore ISI Group | Hold Maintains $28 → $35 | Hold | Maintains | $28 → $35 | -34.85% | Feb 17, 2026 |
Financial Forecast
Revenue This Year
2.11B
from 1.94B
Increased by 8.74%
Revenue Next Year
2.46B
from 2.11B
Increased by 16.18%
EPS This Year
-7.13
from -7.25
EPS Next Year
-5.04
from -7.13
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | 2.4B | 3.6B | |||
| Avg | 2.1B | 2.5B | |||
| Low | 1.8B | 1.8B |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | 21.0% | 69.8% | |||
| Avg | 8.7% | 16.2% | |||
| Low | -9.1% | -15.9% |
EPS Forecast
| EPS | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | -5.29 | -3.54 | |||
| Avg | -7.13 | -5.04 | |||
| Low | -8.87 | -6.29 |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | - | - | |||
| Avg | - | - | |||
| Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.